Sigma Planning Corp’s CapForce IBD 50 ETF FFTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-15,187
Closed -$340K – 961
2023
Q3
$340K Buy
+15,187
New +$367K 0.01% 871
2020
Q1
– Sell
-8,404
Closed -$292K – 980
2019
Q4
$292K Sell
8,404
-9,169
-52% -$310K 0.01% 815
2019
Q3
$567K Sell
17,573
-91,269
-84% -$3.12M 0.03% 537
2019
Q2
$3.73M Buy
108,842
+60,104
+123% +$2.03M 0.19% 131
2019
Q1
$1.63M Sell
48,738
-12,734
-21% -$401K 0.09% 232
2018
Q4
$1.7M Sell
61,472
-775
-1% -$24K 0.12% 176
2018
Q3
$2.39M Buy
62,247
+30,215
+94% +$1.11M 0.14% 158
2018
Q2
$1.12M Buy
32,032
+13,025
+69% +$454K 0.08% 256
2018
Q1
$633K Buy
+19,007
New +$647K 0.05% 372

Other funds holding FFTY

Sigma Planning Corp's FFTY Position: Q4 2023 in Review

Sigma Planning Corp sold out of CapForce IBD 50 ETF (FFTY) in Q4 2023, closing a stake of 15,187 shares — an estimated $340K sold.

Sigma Planning Corp first reported a position in FFTY in Q1 2018 and held it in 9 quarters. The position peaked at $3.73M in Q2 2019. 40 funds tracked by Wall St. Rank hold FFTY as of Q4 2023.

  • Sigma Planning Corp reported no remaining CapForce IBD 50 ETF position as of Q4 2023 after selling out during the quarter.
  • Sigma Planning Corp sold 15,187 CapForce IBD 50 ETF shares in Q4 2023, an estimated $340K.
  • Sigma Planning Corp first reported a position in CapForce IBD 50 ETF in Q1 2018 and held it in 9 quarters.
  • Sigma Planning Corp's CapForce IBD 50 ETF position peaked at $3.73M in Q2 2019.
  • 40 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q4 2023.

Based on Sigma Planning Corp's 13F filing for Q4 2023, filed 1 Feb 2024.